HTA238 Oncological Combination Therapies in the Context of the Early Benefit Assessment According to AMNOG: Status Quo and Quo Vadis
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1921
https://www.valueinhealthjournal.com/article/S1098-3015(23)05051-9/fulltext
Title :
HTA238 Oncological Combination Therapies in the Context of the Early Benefit Assessment According to AMNOG: Status Quo and Quo Vadis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05051-9&doi=10.1016/j.jval.2023.09.1921
First page :
Section Title :
Open access? :
No
Section Order :
11364